Your browser doesn't support javascript.
loading
Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma.
Das, Kalpa Jyoti; Sehgal, Aditi Khurana; Jaiman, Ashish; Sethi, Ravinder Singh.
  • Das KJ; Department of Nuclear Medicine, VMMC and Safdarjung Hospital, New Delhi, India.
  • Sehgal AK; Department of Nuclear Medicine, VMMC and Safdarjung Hospital, New Delhi, India.
  • Jaiman A; Department of Orthopaedics, VMMC and Safdarjung Hospital, New Delhi, India.
  • Sethi RS; Department of Nuclear Medicine, VMMC and Safdarjung Hospital, New Delhi, India.
Indian J Nucl Med ; 30(3): 263-5, 2015.
Article en En | MEDLINE | ID: mdl-26170573
ABSTRACT
Primary hyperparathyroidism is the first differential diagnosis when a patient presents with asymptomatic hypercalcemia. The symptoms of hyperparathyroidism can be as grave as skeletal, cardiovascular, and neuropsychological changes. Skeletal manifestations are relatively common, and patient may present with generalized or focal bone pains, fragility fractures, subperiosteal bone resorption, and osteolytic lesions like brown tumors and salt and pepper appearance of the skull. However, focal osteosclerotic lesions of the skull are rare findings in hyperparathyroidism. Only a few cases of associated osteosclerosis are reported in the literature. Here, we report a case of Tc99m SestaMIBI positive parathyroid adenoma with coexisting osteolytic and osteosclerotic skull lesions on Tc99m methylene diphosphonate bone scan.
Palabras clave